Pharmaceutical
FDA MedWatch Drug Alerts
- Audience: Consumer July 18th, 2026 – Panoli, Gujarat, Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is voluntarily recalling four lots of Cetirizine Hydrochloride Tablets USP 5 mg to the consumer…
- Audience: Health Care Professional, Anesthetist July 2, 2026 — The U.S. Food and Drug Administration (FDA) is investigating the safety of sevoflurane and other general anesthetics based on published scientific reports of unexpected catastrophic…
- Audience: Consumer June 11, 2026, Covina, CA – Beekeeper’s Naturals is voluntarily recalling lot # 5950, Exp. Date 02/2028 of Beekeeper’s Naturals Saline Nasal Spray, sold only through Amazon, to the consumer level. This lot, produced at…
- Audience: Consumer, Patient, Health Care Provider, Pharmacy, Gastroenterology, Nephrology, Endocrinology June 10, 2026 — The FDA has approved changes to the Drugs Facts Label of the over-the-counter (OTC) weight loss drug, alli (orlistat) 60 mg…
- Audience: Health Care Professional, Consumer FRANKLIN LAKES, N.J. (June 06, 2026) – BD (Becton, Dickinson and Company) is voluntarily recalling lot 4032183 of ChloraPrep™ Clear 1 mL Single Sterile and lot 4073005 of FREPP™ Clear…
New Drug Approvals
- Basel, July 17, 2026 – Novartis today announced that the US Food and Drug Administration (FDA) has granted traditional approval for Fabhalta (iptacopan) to slow kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN)…
- RAHWAY, N.J.–(BUSINESS WIRE) July 16, 2026 — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide) tablets 20 mg as an adjunct to…
- On July 14, 2026, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and pediatric patients two years of age and older with locally advanced or metastatic solid tumors with a RET…
- MINNEAPOLIS, July 14, 2026 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for multiple solid tumor indications, today announced that the U.S. Food and Drug…
- TOKYO and CAMBRIDGE, Mass., July 13, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a…
New Drug Applications
- CAMBRIDGE, Mass., July 14, 2026 – Apnimed, Inc., a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing…
- PRINCETON, N.J.–(BUSINESS WIRE) July 13, 2026– Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for mezigdomide in combination with carfilzomib and…
- Fort Lee, N.J., July 10, 2026 – Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for cancer patients, today…
- BOTHELL, Wash. July 8, 2026 – Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced the U.S. Food and Drug Administration (FDA or the…
- ROSWELL, Ga., DUBLIN and HAMILTON, Bermuda — July 7, 2026 — Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug…
Clinical Trial Results
- FOSTER CITY, Calif. & RAHWAY, N.J.–(BUSINESS WIRE) July 21, 2026 — Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the detailed outcomes from the Phase…
- SAN DIEGO—(BUSINESS WIRE) July 21, 2026 — Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to remlifanserin, an investigational, highly…
- London, UK — 17 July 2026 GSK plc (LSE/NYSE: GSK) today provides an update on the CALM-1 and CALM-2 phase III clinical trials, which assessed the efficacy and safety of two doses of camlipixant (a P2X3 receptor antagonist) in adults with…
- Ingelheim, Germany, July 16, 2026 — Boehringer Ingelheim today announces the start of a Phase II clinical trial evaluating its investigational triple GLP-1/GIP/NPY2 receptor agonist, BI 3034701, in patients with obesity and overweight.1 The…
- OSAKA, Japan AND CAMBRIDGE, Massachusetts, July 16, 2026 – Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2)…
Daily Med News
- TUESDAY, July 21, 2026 — Cannabis beverages are increasingly turning up in stores next to iced tea, sodas and even chocolate milk, and doctors warn the easy access is putting kids at risk. The colorful cans contain THC (tetrahydrocannabinol)…
- TUESDAY, July 21, 2026 — Here's some welcome news for coffee lovers. Drinking as many as five cups of caffeinated coffee a day is generally safe for most adults, and may even be linked to cardiovascular benefits, according to a new…
- TUESDAY, July 21, 2026 — More than half of U.S. adults should be taking cholesterol-lowering statin drugs under updated guidelines, a new study says. Earlier this year, the American Heart Association and the American College of Cardiology…
- TUESDAY, July 21, 2026 — Changing the way you walk could offer relief from knee arthritis on par with common painkillers, clinical trial results show. Gait retraining involves making a small adjustment to the angle of your foot — a…
- TUESDAY, July 21, 2026 — Women suffering from pelvic organ prolapse might be best served by a surgery that spares their uterus rather than removing it, a landmark clinical trial reports. Women were less likely to experience treatment failure…
News for Health Professionals
- TUESDAY, July 21, 2026 — Better physician knowledge is associated with lower use of low-value services (LVS), according to a study published online July 13 in JAMA Internal Medicine. Jonathan L. Vandergrift, from the American Board of Internal…
- TUESDAY, July 21, 2026 — In the era of combination quadruplet therapy (QUAD) + autologous stem cell transplantation (ASCT), functional high-risk (FHR) multiple myeloma (MM) should include patients who have disease progression within 36 months of…
- TUESDAY, July 21, 2026 — Social prescribing, which connects people with arts and exercise activities and other support, may help adolescents waiting for specialist mental health services, according to a study published online July 9 in European…
- TUESDAY, July 21, 2026 — For patients with rheumatoid arthritis (RA), the timing of Janus kinase (JAK) inhibitor initiation relative to administration of recombinant zoster vaccine (RZV) can affect early response and arthritis control, according to…
- TUESDAY, July 21, 2026 — Remote patient-reported outcome (PRO) monitoring may improve cancer care for underserved patients, according to a study recently published in JCO Oncology Practice. Allison M. Deal, from the University of North Carolina at…
